Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial

By Palomba Stefano  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3213-3219

Oxford University Press

Access to resources Recommend Favorite

Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene

By Palomba Stefano  

Human Reproduction, Vol. 19, Iss. 2, 2004-02 ,pp. : 415-421

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist protocol administration in the luteal phase in ICSIET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study

By Ata B.   Yakin K.   Balaban B.   Urman B.  

Human Reproduction, Vol. 23, Iss. 3, 2008-03 ,pp. : 668-673

Oxford University Press

Access to resources Recommend Favorite

Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma

By Khan Khaleque Newaz   Kitajima Michio   Hiraki Koichi   Fujishita Akira   Nakashima Masahiro   Ishimaru Tadayuki   Masuzaki Hideaki  

Human Reproduction, Vol. 25, Iss. 11, 2010-11 ,pp. : 2878-2890

Oxford University Press

Access to resources Recommend Favorite

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

By European Middle East Orgalutran® Study Group* The  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 644-651

Oxford University Press

Access to resources Recommend Favorite